Supplementary Figure Legends from Phase I Safety, Pharmacokinetic and Pharmacodynamic Evaluation of the Vascular Disrupting Agent Ombrabulin (AVE8062) in Patients with Advanced Solid Tumors
crossref(2023)
摘要
Supplementary Figure Legends - PDF file 62K, Supplementary Figure legends
查看译文
关键词
vascular disrupting agent ombrabulin,pharmacokinetic,pharmacodynamic evaluation,solid tumors
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要